Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...

32,026 people played the daily Crossword recently. Can you solve it faster than others?32,026 people played the daily Crossword recently. Can you solve it faster than others?

The FDA grants orphan status to medicines and biologics for rare diseases that meet certain criteria, opening the way for incentives such as accelerated approval and tax breaks to support their ...

FDA approval for Unloxcyt was granted based on clinically meaningful objective response rates and duration of response data, as assessed by an independent central review committee from Study CK ...

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease. The Food and Drug Administration (FDA) approved Ryoncil (remestemcel-L-rknd ...

In its second attempt, Takeda has secured FDA approval for Eohilia, which becomes the first and only oral therapy in the US for eosinophilic oesophagitis (EoE). The US regulator has cleared ...

(“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food and Drug Administration (“FDA”) has approved UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic ...

FDA approved Unloxcyt (cosibelimab-ipdl) for advanced or metastatic cSCC ahead of its PDUFA date of Dec. 28. Unloxcyt is the first PD-L1 blocking antibody approved for cSCC, with a recommended ...

Nemluvio is intended for individuals aged 12 years and above with moderate-to-severe atopic dermatitis. Credit: Kmpzzz/Shutterstock. The US Food and Drug Administration (FDA) has approved Galderma‘s ...

2 decision deadline, and extends Vertex’s dominance in the lung disease cystic fibrosis. Prior to Alyftrek’s approval, Vertex had previously brought four cystic fibrosis medicines to market, building ...

Dec. 17, 2024 -- The FDA last week approved Nemluvio for treating moderate to severe atopic dermatitis, a type of eczema, in people aged 12 or older. Nemluvio is to be used with topical ...

The FDA approved tirzepatide (Zepbound) for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity, the agency announced late Friday. Used along with diet and exercise ...